Novartis agrees to acquire Avidity Biosciences, an innovator in RNA therapeutics, strengthening its late-stage neuroscience pipeline

Ad hoc announcement pursuant to Art. 53 LR Transaction strengthens neuroscience franchise for Novartis with three late-stage programs that address genetic neuromuscular diseasesAdvances the Novartis ...

Why Arlo Technologies (ARLO) Is Up 10.8% After Beating Estimates and Raising Its Outlook

In its latest quarterly announcement, Arlo Technologies reported earnings and revenue well above analyst projections, with revenue for the period reaching US$129.4 million compared to expected US$123.